UnitedHealth Group stock: Piper Sandler lifts target to USD 504.00
Published on 10/21/2026 at 17:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and market position
- Piper Sandler raised its UnitedHealth Group target to USD 504.00 from USD 502.00 on October 14, 2026.
- UnitedHealth Group stock stood 9.86 percent below its USD 461.62 52-week high on October 21, 2026.
- UnitedHealth Group stock costs EUR 371.80 at Lang & Schwarz on October 21, 2026 at 5:07 p.m. CEST, minus 0.48 percent versus the Xetra close of October 20, 2026.
- UnitedHealth Group had a USD 373.5 billion market capitalization and a P/E ratio of 23.75 on October 21, 2026.
UnitedHealth Group (ISIN US91324P1021) is the subject of a fresh Piper Sandler target increase to USD 504.00 from USD 502.00, reported on October 14, 2026 by MarketBeat. The new target is 21.12 percent above the USD 416.10 NYSE quote at 11:13 a.m. ET on October 21, 2026. At Lang & Schwarz, the stock stood at EUR 371.80 on October 21, 2026 at 5:07 p.m. CEST, minus 0.48 percent versus the Xetra close of October 20, 2026 at EUR 373.60.
Target leaves room above the quote
Piper Sandler kept its Overweight rating while lifting the target by USD 2.00, a 0.40 percent increase from USD 502.00. The firm is one of several houses updating views after the insurer's latest quarterly report, but the target remains below the USD 529.00 level cited by Morgan Stanley in a separate October report.
Stock sits below its yearly high
The NYSE quote was USD 416.10 at 11:13 a.m. ET on October 21, 2026. UnitedHealth Group's 52-week range was USD 255.97 to USD 461.62, putting the stock 9.86 percent below its high and 62.56 percent above its low. Volume stood at 1,094,827 shares, while the market capitalization was USD 373.5 billion.
Valuation and the latest report date
UnitedHealth Group traded at a P/E ratio of 23.75 and a dividend yield of 2.00 percent on October 21, 2026. The company's latest quarterly release was dated October 13, 2026, according to its UnitedHealth Group release. The release reported third-quarter revenue of USD 112.7 billion and operating earnings of USD 6.6 billion.
Comparison with peers
UnitedHealth Group: minus 0.48 percent versus the Xetra close, P/E 23.75, market capitalization USD 373.5 billion on October 21, 2026.
Humana: minus 0.05 percent, P/E 40.51, market capitalization USD 51.3 billion on October 21, 2026.
Elevance Health: minus 1.15 percent, P/E 1.86, market capitalization USD 94.4 billion on October 21, 2026.
Price remains below the annual peak
UnitedHealth Group's euro quotation was EUR 371.80 at Lang & Schwarz on October 21, 2026 at 5:07 p.m. CEST, minus 0.48 percent against the Xetra close of October 20, 2026 at EUR 373.60. The further course of trading is shown by the continuously updated real-time quote of UnitedHealth Group stock.
UnitedHealth Group market data
- Company: UnitedHealth Group Incorporated
- ISIN: US91324P1021
- Ticker: UNH
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 21, 2026, 5:07 p.m. CEST): EUR 371.80
- Change versus Xetra close: minus 0.48 percent
- Xetra close (October 20, 2026): EUR 373.60
- Market capitalization: USD 373.5 billion (as of October 21, 2026)
- 52-week range: USD 255.97-461.62 (as of October 21, 2026)
- Sector / Industry: Healthcare / Medical - Healthcare Plans
Market context: Market report S&P 500.
